Category
Simvastatin
CAS Number
145576-25-6
Molecular Formula
C₂₇H₄₀O₆
Molecular Weight
460.60 g/mol
Synonym

4'-Acetyl Simvastatin; 2,2-Dimethylbutanoic Acid (1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-(Acetyloxy)tetrahydro -6-oxo-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-1-naphthalenyl Ester; Simvastatin Acetate; (1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-(acetyloxy)-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate (as per EP) ; (1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-(Acetyloxy)-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate.(as per USP); Simvastatin USP Related Compound B ; Simvastatin Acetate Ester ; Acetyl simvastatin (USP)

Keywords
Chiral standards
Impurities
Pharmaceutical Standards
Intermediates
Fine Chemicals
Impurities manufacturer and Suppliers in Hyderabad india
slide.1

Accelerate your active ingredient purity mapping with premium Simvastatin EP Impurity B, developed under strict laboratory controls by Manasa Life Sciences, your reliable manufacturer and supplier of complex reference molecules. This critical lipophilic compound, cataloged as Simvastatin Impurity B or Simvastatin acetate ester, possessing the CAS Number 145576-25-6, molecular formula C₂₇H₄₀O₆ and a molecular weight of 460.60 g/mol and chemical name (1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-(acetyloxy)-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate. Synthesized under rigorous GMP baselines, this high-purity pharmaceutical impurities Simvastatin B variant is fully mapped by HPLC and robust LCMS protocols to confirm definitive peak separation. Each batch is supported by a comprehensive regulatory packet containing a validated COA, detailed structural NMR spectra, an illustrative Simvastatin Impurity B HPLC profile, and a comprehensive MSDS. Distributed via GDP compliant logistics, this standard helps researchers track process-related impurities to satisfy ICH limit guidelines, facilitating seamless regulatory filings before the USFDA, EMA, and related international pharmacopeia bodies.